Prognostic factors for survival and factors associated with long-term remission in patients with advanced melanoma receiving cytokine-based treatments

Analysis of survival by tumor response.

J R Anderson, Kevin C. Cain, RD Gelber · Journal of Clinical Oncology · 1983 · 1.1K citations

Medicine, Biostatistics, Oncology +15

Experience with the Use of High-Dose Interleukin-2 in the Treatment of 652 Cancer Patients

Steven A. Rosenberg, Michael T. Lotze, James Chih‐Hsin Yang et al. · Annals of Surgery · 1989 · 1K citations

Medicine, Immunology, Oncology +17

Analysis of survival by tumor response.

J R Anderson, Robert B. Davis · Journal of Clinical Oncology · 1986 · 1K citations

Medicine, Biostatistics, Oncology +15

Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic Melanoma

Paul B. Chapman, Lawrence H. Einhorn, Michael L. Meyers et al. · Journal of Clinical Oncology · 1999 · 763 citations

Medicine, Oncology, Pharmacology +11

Prognostic factors in 1,521 melanoma patients with distant metastases.

Andreas S. Barth, Leslie A. Wanek, D L Morton · PubMed · 1995 · 573 citations

Medicine, Oncology, Surgery +16